Medicinal And Botanical Manufacturing federal obligations in FY2024

325411 dollars tagged to FY2024

NAICS 325411 and fiscal year 2024 form one pair. $9,261,326,530.04 is the obligation sum USAspending.gov attaches to that pair. It is not pharmaceutical preparation manufacturing (325412), not biological product manufacturing (325414), and not an outlay. Bulk medicinal and botanical manufacturing is a different Census class from finished-dose or biologic product codes on this slice. The packet does not name makers.

A thick action file can look like a claims register. 293,920 is extract-wide. Ranking products from $9,261,326,530.04 would invent a table. Correlation with shortage headlines is not causation.

FY2024 versus 325411's extract-wide total

65.2% of $14,205,648,718.03 sits on the FY2024 yearlyTrend row. The industry hub (/industries/325411/) drops the year filter. FY2024 federal spending (/fiscal-years/2024/) drops the 325411 filter. Neither parent equals $9,261,326,530.04.

Do not add 325412's FY2025 cell or 325414's FY2024/FY2025 cells into $9,261,326,530.04. Cite obligations, not invoices already settled at a named plant.

How to read 325411's 293,920 award records

293,920 is an unusually thick industry-extract action count, on the same order as petroleum refineries on this slice. Dividing $9,261,326,530.04 by 293,920 would mix a one-year dollar field with a multi-year row field and would understate any implied FY-only mean. This page does not publish that blend.

What the 325411–FY2024 packet leaves out

No outlays, no product pie, no named manufacturers, no state table. Campaign-finance filings do not fund these USAspending obligations. Quote NAICS 325411, FY2024, and $9,261,326,530.04 together. All industries (/industries/) and All spending ties (/ties/) list other keys that must stay outside this cell.

Citing medicinal and botanical manufacturing in FY2024

Use /industries/325411/ for the 325411 hub, /fiscal-years/2024/ for the FY2024 government-wide hub, /industries/ for the industry index, and /ties/ for other pairs. Keep Medicinal And Botanical Manufacturing and FY2024 on the same line as $9,261,326,530.04.

The 293,920 award-record figure stays attached to NAICS 325411's extract, not to this yearlyTrend row. Original award filings remain on USAspending.gov. Obligations of $9,261,326,530.04 are not outlays. Keep Medicinal And Botanical Manufacturing and FY2024 together when citing $9,261,326,530.04. NAICS 325411's extract-wide award-record count is 293,920, not a FY2024 census. Obligations of $9,261,326,530.04 are not outlays. Original filings remain on USAspending.gov for this 325411 × FY2024 pair. Do not add parent hubs into this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. The 65.2% share is $9,261,326,530.04 divided by the extract-wide $14,205,648,718.03, not a budget score. Unique recipients remain unpublished on this Medicinal And Botanical Manufacturing FY2024 join. Agency and place-of-performance splits are omitted from this packet. Quote NAICS 325411, fiscal year 2024, and $9,261,326,530.04 in one sentence. The All industries index and All spending ties index are larger than this cell. A later USAspending ingest can restate $9,261,326,530.04 without changing the join keys. Keep Medicinal And Botanical Manufacturing and FY2024 together when citing $9,261,326,530.04. NAICS 325411's extract-wide award-record count is 293,920, not a FY2024 census. Obligations of $9,261,326,530.04 are not outlays. Original filings remain on USAspending.gov for this 325411 × FY2024 pair. Do not add parent hubs into this yearlyTrend cell. Campaign-finance tables do not fund these USAspending obligations. The 65.2% share is $9,261,326,530.04 divided by the extract-wide $14,205,648,718.03, not a budget score. Unique recipients remain unpublished on this Medicinal And Botanical Manufacturing FY2024 join. Agency and place-of-performance splits are omitted from this packet. Quote NAICS 325411, fiscal year 2024, and $9,261,326,530.04 in one sentence.

Questions

How much did Medicinal And Botanical Manufacturing obligate in FY2024?

USAspending.gov records $9,261,326,530.04 in Medicinal And Botanical Manufacturing obligations for FY2024 under NAICS 325411. That yearlyTrend total is not an outlay and not the industry's $14,205,648,718.03 extract-wide sum. Keep Medicinal And Botanical Manufacturing and FY2024 on the same citation as $9,261,326,530.04.

Is this the same as pharmaceutical preparation manufacturing?

No. This join is NAICS 325411. Finished-dose pharmaceutical preparation is 325412. FY2024 is 65.2% of 325411's $14,205,648,718.03 extract-wide total. 293,920 is the industry extract award-record count, not a FY2024 headcount. The pair is NAICS 325411 plus FY2024.

Are 293,920 awards the FY2024 medicinal contract count?

No. 293,920 is the 325411 extract award-record count, not a FY2024-only tally. The packet does not name makers. Obligations of $9,261,326,530.04 are not outlays. The pair is NAICS 325411 plus FY2024. The pair is NAICS 325411 plus FY2024.

Does this page report products already delivered?

No. $9,261,326,530.04 is an obligation aggregate. Outlays and lot counts are unpublished. FEC donations are a different dataset and do not fund this total. USAspending.gov remains the source for NAICS 325411 in FY2024. The pair is NAICS 325411 plus FY2024.